---
title: "Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296396513.md"
description: "On August 19, 2026, in Woburn, Massachusetts, Replimune Group, Inc. revealed that the Company's Chief Commercial Officer, Michelle DiNapoli, was granted inducement equity awards. Replimune Group, Inc., listed on NASDAQ as REPL, is a biotechnology company in the commercial stage focusing on innovative oncolytic immunotherapies."
datetime: "2026-08-19T20:02:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296396513.md)
  - [en](https://longbridge.com/en/news/296396513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296396513.md)
generator: "portal-rs"
---

# Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

On August 19, 2026, in Woburn, Massachusetts, Replimune Group, Inc. revealed that the Company's Chief Commercial Officer, Michelle DiNapoli, was granted inducement equity awards. Replimune Group, Inc., listed on NASDAQ as REPL, is a biotechnology company in the commercial stage focusing on innovative oncolytic immunotherapies.

### Related Stocks

- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)

## Related News & Research

- [Replimune management to present fireside chat at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297910099.md)
- [17:00 ETReplimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/296955124.md)
- [14:21 ETNew Poll Shows Ed Markey's Support Slipping in Deep Blue Massachusetts](https://longbridge.com/en/news/297947167.md)
- [MiniLuxe forms joint venture with Vera Vos-Lexmond for Mansfield, Massachusetts studio](https://longbridge.com/en/news/297904156.md)
- [KeyBank Opens New Black Diamond Branch, Donates $20,000 to Local Nonprofits](https://longbridge.com/en/news/297540698.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**